These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2499960)

  • 1. Adoption of new methods for high-yield factor VIII recovery.
    Rock G
    Transfusion; 1989 Jun; 29(5):466-7. PubMed ID: 2499960
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ; Mathews RW; Fulton AJ
    Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thaw-siphon technique for factor-VIII cryoprecipitate.
    Foster P; White B
    Lancet; 1978 Sep; 2(8089):574. PubMed ID: 79936
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.
    Farrugia A
    Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters affecting the fractionation of FVIII:C activity in production of very high purity AHF concentrate.
    Törmä E; Myllylä G
    Scand J Haematol Suppl; 1984; 40():123-6. PubMed ID: 6433441
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractionation of plasma with polyethylene glycol.
    Polson A; Ruiz-Bravo C
    Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
    [No Abstract]   [Full Text] [Related]  

  • 8. Precipitation methods in plasma fractionation.
    Steinbuch M
    Vox Sang; 1972; 23(1):92-106. PubMed ID: 5081018
    [No Abstract]   [Full Text] [Related]  

  • 9. Present state and perspectives of the farctionation of human plasma, serum and placenta.
    Richter P
    Ann Immunol Hung; 1973; 17():85-92. PubMed ID: 4142679
    [No Abstract]   [Full Text] [Related]  

  • 10. Important parameters in plasma fractionation.
    Lane RS
    Vox Sang; 1986; 51 Suppl 1():49-51. PubMed ID: 3090786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters.
    te Booy MP; Faber A; de Jonge E; Wolterink EP; Riethorst W; Beugeling T; Bantjes A; Over J; König BW
    J Chromatogr; 1990 Mar; 503(1):103-14. PubMed ID: 2111329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophoretic studies of human plasma cryoprecipitates with a high content of antihemophilic globulin A].
    Kleint V; Wegner H
    Z Gesamte Inn Med; 1970 Apr; 25(7):312-4. PubMed ID: 5521442
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fractionation in the United States. A review for clinicians.
    Ness PM; Pennington RM
    JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences in the preparation and analytical control of Cohn's plasma fraction I].
    Hofmann F; Thomas K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):316-9. PubMed ID: 4195275
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in cryoprecipitate production.
    Rock G; Tittley P
    Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.